Lu H - Search Results

1

Physical mechanisms of red blood cell splenic filtration.

Moreau A, Yaya F, Lu H, Surendranath A, Charrier A, Dehapiot B, Helfer E, Viallat A, Peng Z. Moreau A, et al. Among authors: lu h. Proc Natl Acad Sci U S A. 2023 Oct 31;120(44):e2300095120. doi: 10.1073/pnas.2300095120. Epub 2023 Oct 24. Proc Natl Acad Sci U S A. 2023. PMID: 37874856 Free PMC article.

2

Reply to Kaestner et al.: Activation of PIEZO1 is not significant for the passage of red blood cells through biomimetic splenic slits.

Moreau A, Yaya F, Lu H, Surendranath A, Charrier A, Dehapiot B, Helfer E, Viallat A, Peng Z. Moreau A, et al. Among authors: lu h. Proc Natl Acad Sci U S A. 2025 Jan 14;122(2):e2411469121. doi: 10.1073/pnas.2411469121. Epub 2025 Jan 2. Proc Natl Acad Sci U S A. 2025. PMID: 39746004 Free article. No abstract available.

3

Comparing acute versus AIDS ART initiation on HIV-1 integration sites and clonal expansion.

Wang J, Xiao N, Zhu Z, Qiao H, Zhao F, Zhang L, Gou J, Lu M, He Y, Lu H, Li Q. Wang J, et al. Among authors: lu h. Signal Transduct Target Ther. 2025 Jan 10;10(1):23. doi: 10.1038/s41392-024-02113-7. Signal Transduct Target Ther. 2025. PMID: 39788938

4

Flexible disk ultramicroelectrode: Facile preparation and high-resolution scanning electrochemical microscopy imaging.

Zhang X, Mei X, Bao J, Song P, Lu H, Han C, Xu W. Zhang X, et al. Among authors: lu h. Anal Chim Acta. 2025 Jan 22;1336:343490. doi: 10.1016/j.aca.2024.343490. Epub 2024 Nov 27. Anal Chim Acta. 2025. PMID: 39788661

5

SCPL48 regulates the vessel cell programmed cell death during xylem development in Arabidopsis thaliana.

Zhang C, Shen M, Xu Y, Sun Y, Sun L, Fan Y, Li H, Lu H. Zhang C, et al. Among authors: lu h. Int J Biol Macromol. 2025 Jan 7:139495. doi: 10.1016/j.ijbiomac.2025.139495. Online ahead of print. Int J Biol Macromol. 2025. PMID: 39788248

6

Evaluation of the natural suitability of human settlements in the Western Sichuan Plateau region of China.

Feng W, Lu H, Xiang M. Feng W, et al. Among authors: lu h. Sci Rep. 2025 Jan 10;15(1):1552. doi: 10.1038/s41598-025-85732-6. Sci Rep. 2025. PMID: 39789172

7

Discovery of Potent, Highly Selective, and Orally Bioavailable MTA Cooperative PRMT5 Inhibitors with Robust In Vivo Antitumor Activity.

Zhang M, Ding X, Cao Z, Yang Y, Ding X, Cai X, Zhang M, Aliper A, Ren F, Lu H, Zhavoronkov A. Zhang M, et al. Among authors: lu h. J Med Chem. 2025 Jan 9. doi: 10.1021/acs.jmedchem.4c02732. Online ahead of print. J Med Chem. 2025. PMID: 39787362

8

The analysis of molecular classification of pulmonary neuroendocrine tumors and relationship between YAP1 and efficacy.

Li M, Wang X, Gong J, Lu H. Li M, et al. Among authors: lu h. Invest New Drugs. 2025 Jan 9. doi: 10.1007/s10637-024-01492-6. Online ahead of print. Invest New Drugs. 2025. PMID: 39786663

9

Surgical treatment can provide the opportunity for in-vitro fertilization (IVF) in a shorter period of time for patients with early-stage endometrial cancer.

Xu Q, Lu H, Wang X, Li M, Zou W. Xu Q, et al. Among authors: lu h. Discov Oncol. 2025 Jan 9;16(1):24. doi: 10.1007/s12672-025-01750-w. Discov Oncol. 2025. PMID: 39786518

10

Phase 2 Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1 Pretreated Metastatic Non-Small Cell Lung Cancer and Metastatic Cutaneous Melanoma.

Lee S, Hamid O, Jotte R, Zakharia Y, Medina T, Gillespie-Twardy A, Mehmi I, Chandra S, Watson G, Ward P, Chaney M, Lu H, Berndt J, O'Connor BP, Rathi K, Shaikh E, Cowey CL. Lee S, et al. Among authors: lu h. Clin Cancer Res. 2024 Dec 30. doi: 10.1158/1078-0432.CCR-24-1478. Online ahead of print. Clin Cancer Res. 2024. PMID: 39786430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,253 results

Search Page

Filters